BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3906166)

  • 1. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical bacteriological efficacy study on a fosfomycin otic solution].
    Deguchi K; Yokota N; Tanaka S; Fukayama S; Nishimura Y; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
    Jpn J Antibiot; 1986 Sep; 39(9):2344-54. PubMed ID: 3099028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical laboratory approach for estimating effective administrative dosage of cefmenoxime. Observation on the MICS and cefmenoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1984 May; 37(5):791-801. PubMed ID: 6090721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of antibacterial activity of cefmenoxime with other cephalosporins against clinically isolated bacteria (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1981 Oct; 34(10):1366-86. PubMed ID: 6278174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteriological evaluation of ofloxacin otic solution].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1342-55. PubMed ID: 1479686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
    Takahashi C; Miyazawa K
    Jpn J Antibiot; 1985 Jan; 38(1):27-30. PubMed ID: 3886949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory and clinical studies of cefmenoxime in the pediatric field].
    Sekiguchi T; Miyao M; Kokawa T; Uyama Y; Mizui M; Tanaka H
    Jpn J Antibiot; 1982 Nov; 35(11):2570-7. PubMed ID: 6302338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic and clinical studies on cefmenoxime in pediatric field].
    Iwata S; Iwasaki Y; Kanemitsu T; Akita H; Hotta M; Yamashita N; Nanri S; Wakabayashi R; Kojima Y; Sunakawa K; Osano M; Ichihashi Y; Tachibana Y; Takahashi H; Kori T
    Jpn J Antibiot; 1982 Oct; 35(10):2440-9. PubMed ID: 6306295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effects of cefmenoxime in the treatment of various infections on infants and children].
    Kurashige T; Wakiguchi H; Kitamura I; Ozaki H; Nishibayashi Y; Hamawaki M
    Jpn J Antibiot; 1982 Nov; 35(11):2579-88. PubMed ID: 6302339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1989 Oct; 42(10):2141-73. PubMed ID: 2691714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activities of cefmenoxime against recent clinical isolates from patients of otitis media and otitis externa].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Oct; 46(10):850-9. PubMed ID: 8254887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro antibacterial activity of various cephems against clinical isolates from complicated urinary tract infections].
    Kamidono S; Fujii A; Arakawa S; Kataoka N; Ishigami J
    Jpn J Antibiot; 1985 Jan; 38(1):179-89. PubMed ID: 3989977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on penetration of antibiotics to gallbladder tissue and bile, its surgical significance. Mainly with cefmenoxime].
    Tsuburaya H; Watanabe I; Endo S; Oikawa M
    Jpn J Antibiot; 1985 Jan; 38(1):31-40. PubMed ID: 3857360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.